The Patent Finder

U.S. Biotest, Inc.

Also on record
Records under this name other than patents U.S. Biotest, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 8 of 8 · Back to U.S. Biotest, Inc.

PatentTitleStatus Expires Confidence
US 10,398,646Methods for Treating Lung Disorders
now held by Crititech, Inc.
In force
 · High confidence
In forceHigh confidence
US 10,507,181Methods for Treating Lung Disorders
now held by Crititech, Inc.
In force
 · High confidence
In forceHigh confidence
16/239,530Use of Antineoplastic Agents to Stimulate the Immune System for Treatment of Cancer
now held by Crititech, Inc.
Abandoned
Abandoned Jun 17, 2020
AbandonedAbandoned Jun 17, 2020
16/239,531Treatment of Kidney Tumors by Intratumoral Injection of Taxane Particles
now held by Crititech, Inc.
Abandoned
Abandoned Jun 1, 2020
AbandonedAbandoned Jun 1, 2020
16/382,446Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles
now held by Crititech, Inc.
Abandoned
Abandoned Jun 11, 2021
AbandonedAbandoned Jun 11, 2021
16/383,023Methods for Isolating Tumor-Specific Immune Cells from a Subject for Adoptive Cell Therapy and Cancer Vaccines
now held by Crititech, Inc.
Abandoned
Abandoned Sep 28, 2020
AbandonedAbandoned Sep 28, 2020
17/381,705Sorafenib particles and uses thereof
now held by Crititech, Inc.
Abandoned
Abandoned Jul 28, 2023
AbandonedAbandoned Jul 28, 2023
17/381,786Lapatinib particles and uses thereof
now held by Crititech, Inc.
Abandoned
Abandoned Jul 27, 2022
AbandonedAbandoned Jul 27, 2022
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited